People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NEXTWAVE PHARMACEUTICALS Inc | — | Pharmaceuticals | Series B | $27.2M | $925.9M | 2011 |
Craig Chambliss at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Craig Chambliss on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANAND MEHRA | 1 | 7 |
| Steve Elms | 1 | 4 |
| Dayton Misfeldt | 1 | 4 |
| Linda Ara | 1 | 3 |
| Gaurav Aggarwal | 1 | 3 |
| Jay Shepard | 1 | 3 |
| Frank Kung | 1 | 2 |
| Michael Burdick | 1 | 2 |
| Robert Casale | 1 | 2 |
| Patrick Zenner | 1 | 1 |
| Hingge Hsu | 1 | 1 |
| Sally Berry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.